Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
- PMID: 15546503
- PMCID: PMC11159131
- DOI: 10.1111/j.1349-7006.2004.tb02195.x
Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
Abstract
BRCA1 (BReast-CAncer susceptibility gene 1) and BRCA2 are tumor suppressor genes, the mutant phenotypes of which predispose to breast and ovarian cancers. Intensive research has shown that BRCA proteins are involved in a multitude of pivotal cellular processes. In particular, both genes contribute to DNA repair and transcriptional regulation in response to DNA damage. Recent studies suggest that BRCA proteins are required for maintenance of chromosomal stability, thereby protecting the genome from damage. New data also show that BRCAs transcriptionally regulate some genes involved in DNA repair, the cell cycle, and apoptosis. Many of these functions are mediated by a large number of cellular proteins that interact with BRCAs. The functions of BRCA proteins are also linked to distinct and specific phosphorylation events; however, the extent to which phosphorylation-activated molecular pathways contribute to tumor suppressor activity remains unclear. Finally, the reasons why mutations in BRCA genes lead to the development of breast and ovarian cancers are not clearly understood. Elucidation of the precise molecular functions of BRCAs is expected to improve our understanding of hereditary as well as sporadic mammary carcinogenesis.
Similar articles
-
The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.Front Biosci (Landmark Ed). 2014 Jan 1;19(4):605-18. doi: 10.2741/4230. Front Biosci (Landmark Ed). 2014. PMID: 24389207 Free PMC article. Review.
-
BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair.Carcinogenesis. 2010 Jun;31(6):961-7. doi: 10.1093/carcin/bgq069. Epub 2010 Apr 16. Carcinogenesis. 2010. PMID: 20400477 Review.
-
BRCA1 gene in breast cancer.J Cell Physiol. 2003 Jul;196(1):19-41. doi: 10.1002/jcp.10257. J Cell Physiol. 2003. PMID: 12767038 Review.
-
Cancer susceptibility and the functions of BRCA1 and BRCA2.Cell. 2002 Jan 25;108(2):171-82. doi: 10.1016/s0092-8674(02)00615-3. Cell. 2002. PMID: 11832208 Review.
-
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.Hum Mol Genet. 2001 Apr;10(7):705-13. doi: 10.1093/hmg/10.7.705. Hum Mol Genet. 2001. PMID: 11257103 Review.
Cited by
-
A comprehensive analysis of minimally differentially methylated regions common to pediatric and adult solid tumors.NPJ Precis Oncol. 2024 Jun 1;8(1):125. doi: 10.1038/s41698-024-00590-1. NPJ Precis Oncol. 2024. PMID: 38824198 Free PMC article.
-
Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients.Breast Cancer Res Treat. 2024 May 30. doi: 10.1007/s10549-024-07362-2. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38814507
-
β-D-Glucan promotes NF-κB activation and ameliorates high-LET carbon-ion irradiation-induced human umbilical vein endothelial cell injury.Turk J Med Sci. 2023 Sep 21;53(6):1621-1634. doi: 10.55730/1300-0144.5731. eCollection 2023. Turk J Med Sci. 2023. PMID: 38813508 Free PMC article.
-
PARP inhibitor synthetic lethality in ATM biallelic mutant cancer cell lines is associated with BRCA1/2 and RAD51 downregulation.Front Oncol. 2024 May 14;14:1380633. doi: 10.3389/fonc.2024.1380633. eCollection 2024. Front Oncol. 2024. PMID: 38807759 Free PMC article.
-
Cellular mechanisms mediating the anti-cancer effects of carnosol on gingiva carcinoma.Sci Rep. 2024 May 28;14(1):12266. doi: 10.1038/s41598-024-60797-x. Sci Rep. 2024. PMID: 38806527 Free PMC article.
References
-
- Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. J Cell Physiol 2003; 196: 19–41. - PubMed
-
- Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. Linkage of early‐onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684–9. - PubMed
-
- Smith SA, Easton DF, Evans DG, Ponder BA. Allele losses in the region 17ql2–21 in familial breast and ovarian cancer involve the wild‐type chromosome. Nat Genet 1992; 2: 128–31. - PubMed
-
- Neuhausen SL, Marshall CJ. Loss of heterozygosity in familial tumors from three BRCAl‐linked kindreds. Cancer Res 1994; 54: 6069–72. - PubMed
-
- Miki Y, Swensen J, Shattuck‐Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66–71. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous